Biggest News Aggregation in the World
📰 Brian Lenz News

Brian Lenz News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Brian Lenz. Real-time updates on events, politics, business and more.

ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2023 Earnings Call Transcript

ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2023 Earnings Call Transcript February 28, 2024 ADMA Biologics, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $0.02. ADMA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. And welcome […]
United States Anthony Petrone Brian Lenz Adam Grossman Executive Vice President General Manager
Source: yahoo.com

FY2024 EPS Estimates for ADMA Biologics, Inc. Boosted by Analyst (NASDAQ:ADMA)

ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) – Cantor Fitzgerald raised their FY2024 EPS estimates for shares of ADMA Biologics in a note issued to investors on Thursday, November 9th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will post earnings per share of $0.18 for the year, up from their previous […]
United States Sakhalinskaya Oblast Adams Grossman Raymond James Brian Lenz Cantor Fitzgerald

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

ADMA Biologics (ADMA) to Release Quarterly Earnings on Wednesday

ADMA Biologics (NASDAQ:ADMA – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Wednesday, November 8th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. ADMA […]
United States Raymond James Adams Grossman Brian Lenz Bleakley Financial Group Securities Exchange Commission
Source: wkrb13.com

ADMA Biologics (NASDAQ:ADMA) Downgraded by StockNews.com

StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a report issued on Sunday morning. Several other analysts have also recently commented on ADMA. TheStreet upgraded ADMA Biologics from a d rating to a c- rating in a report on Friday, May 19th. Cantor Fitzgerald […]
United States Raymond James Adams Grossman Brian Lenz Vanguard Group Inc Biologics Inc

ADMA Biologics (NASDAQ:ADMA) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a sell rating to a hold rating in a report published on Saturday morning. Several other analysts have also recently commented on the company. Cantor Fitzgerald raised their target price on ADMA Biologics from $5.00 to $6.00 and gave the company an overweight rating […]
United States Brian Lenz Kyoung Kwon Raymond James Securities Exchange Commission Biologics Inc
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science